Antibiotics and risk of IBD-Can we close the books? Authors' reply

被引：0

作者：

Oh, Shin Ju ^{[1
]}

Kim, Hyo Jong ^{[1
]}

Lee, Chang Kyun ^{[1
]}

机构：

[1] Kyung Hee Univ, Coll Med, Ctr Crohns & Colitis, Dept Gastroenterol, Seoul, South Korea

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 02期

关键词：

INFLAMMATORY-BOWEL-DISEASE; POPULATION;

D O I：

10.1111/apt.17608

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LINKED CONTENT This article is linked to Oh et al papers. To view these articles, visit and

引用

页码：256 / 257

页数：2

共 49 条

[21] Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?: Authors' Reply
Bolia, Rishi
Srivastava, Anshu
INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (08): : 840 - 840
[22] Progression of renal disease - can we forget about inhibition of the renin-angiotensin system? Authors' reply
Casas, Juan Pablo
Hingorani, Aroon D.
MacAllister, Raymond J.
Smeeth, Liam
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2352 - 2353
[23] Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply
Dong, Catherine
Metzger, Marie
Holsbo, Einar E.
Perduca, Vittorio
Carbonnel, Franck
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1445 - 1446
[24] Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?: Authors’ Reply
Rishi Bolia
Anshu Srivastava
Indian Journal of Pediatrics, 2022, 89 : 840 - 840
[25] Editorial: mesalamine and mucosal microbiome in quiescent ulcerative colitis-what can we learn? Authors' reply
Olaisen, Maya
Fossmark, Reidar
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (12) : 1532 - 1532
[26] Authors' Response to the Letter to the Editor Entitled: How Can We Interpret Insomnia as a "Risk Factor" on Behavioral Symptom
Chekani, Farid
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2024, 25 (03) : 554 - 554
[27] REPLY FROM AUTHORS: SEMANTICS AGAINST IMPROVING OUTCOME OF TYPE A DISSECTION SURGERY: WE CAN WIN THE BATTLE, BUT HOW NOT TO LOSE THE WAR?
Rylski, Bartosz
Kallenbach, Klaus
Beyersdorf, Friedhelm
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 160 (02): : E11 - E13
[28] The Promotion of Health and the Integrated Prevention of Risk Factors for Cardiovascular Diseases: until when we will be "mopping up the ice"? The authors reply
不详
CIENCIA & SAUDE COLETIVA, 2012, 17 (01):
[29] Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply
Bertani, Lorenzo
Pugliese, Daniela
Trico, Domenico
Costa, Francesco
Blandizzi, Corrado
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (02) : 348 - 349
[30] Enhancing the Rigor of Research on Herpes Zoster Risk in IBD Patients Post-SARS-CoV2: Recommendations for Global and Detailed Analyses-Authors' Reply
Desai, Aakash
Farraye, Francis A.
Caldera, Freddy
INFLAMMATORY BOWEL DISEASES, 2024,

← 1 2 3 4 5 →